Lakewood Capital Management’s Ascendis Pharma A/S ASND Stock Holding History

Lakewood Capital Management’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-18,100	Closed	-$2.88M	–	66
2021 Q3	$2.88M	Sell	18,100 -59,350	-77%	-$8.12M	0.13%	55
2021 Q2	$10.2M	Sell	77,450 -4,000	-5%	-$533K	0.42%	46
2021 Q1	$10.5M	Sell	81,450 -14,000	-15%	-$2.13M	0.45%	44
2020 Q4	$15.9M	Sell	95,450 -20,000	-17%	-$3.31M	0.75%	37
2020 Q3	$17.8M	Sell	115,450 -15,000	-11%	-$2.16M	0.86%	39
2020 Q2	$19.3M	Sell	130,450 -20,000	-13%	-$2.75M	0.83%	38
2020 Q1	$16.9M	Sell	150,450 -120,000	-44%	-$15.6M	0.77%	33
2019 Q4	$37.6M	Sell	270,450 -40,000	-13%	-$4.44M	1.33%	23
2019 Q3	$29.9M	Sell	310,450 -457,743	-60%	-$51.1M	1.02%	23
2019 Q2	$88.5M	Sell	768,193 -240,000	-24%	-$28.7M	2.7%	14
2019 Q1	$119M	Buy	1,008,193 +198,600	+25%	+$17.4M	3.33%	13
2018 Q4	$50.7M	Buy	809,593 +23,100	+3%	+$1.45M	1.67%	19
2018 Q3	$55.7M	Buy	786,493 +335,967	+75%	+$23.1M	1.84%	19
2018 Q2	$30M	Buy	+450,526	New	+$29.6M	0.99%	22

Other funds holding ASND

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Lakewood Capital Management's ASND Position: Q4 2021 in Review

Lakewood Capital Management sold out of Ascendis Pharma A/S (ASND) in Q4 2021, closing a stake of 18,100 shares — an estimated $2.88M sold.

Lakewood Capital Management first reported a position in ASND in Q2 2018 and held it in 14 quarters. The position peaked at $119M in Q1 2019. 172 funds tracked by Wall St. Rank hold ASND as of Q4 2021.

Lakewood Capital Management reported no remaining Ascendis Pharma A/S position as of Q4 2021 after selling out during the quarter.
Lakewood Capital Management sold 18,100 Ascendis Pharma A/S shares in Q4 2021, an estimated $2.88M.
Lakewood Capital Management first reported a position in Ascendis Pharma A/S in Q2 2018 and held it in 14 quarters.
Lakewood Capital Management's Ascendis Pharma A/S position peaked at $119M in Q1 2019.
172 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q4 2021.

Based on Lakewood Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.